Monoclonal antibodies, new technologies, and critical care medicine

C. L. Sprung*, L. A. Eidelman

*Corresponding author for this work

Research output: Contribution to journalEditorial

2 Scopus citations
Original languageEnglish
Pages (from-to)1114-1116
Number of pages3
JournalCritical Care Medicine
Volume21
Issue number8
DOIs
StatePublished - 1993
Externally publishedYes

Keywords

  • Gram-negative bacteria
  • cost effectiveness
  • endotoxin
  • monoclonal antibodies

Cite this